SCHEMBL8060432

SCHEMBL8060432

CC(C)(C)OC(=O)N1C[C@H]2CCN(Cc3ccccc3)CC[C@H]2C1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.58
JAK1 P23458 1/20 0.58
GPR119 Q8TDV5 3/20 0.55
STS P08842 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
TSHR P16473 1/20 0.49
TP53 P04637 2/20 0.48
THRB P10828 1/20 0.48
MAPT P10636 1/20 0.48
BCHE P06276 1/20 0.48
ACHE P22303 1/20 0.48
CHRM4 P08173 1/20 0.47
KDM4E B2RXH2 1/20 0.47
PKM P14618 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4470679 1.00 JAK2 (0.58) JAK2JAK1GPR119STSMEN1
SCHEMBL8056082 1.00 JAK2 (0.58) JAK2JAK1GPR119STSMEN1
SCHEMBL8056077 1.00 JAK2 (0.58) JAK2JAK1GPR119STSMEN1
SCHEMBL3642479 0.95 JAK2 (0.56) JAK2JAK1GPR119STSMEN1
SCHEMBL16963755 0.95 JAK2 (0.56) JAK2JAK1GPR119STSMEN1
SCHEMBL3335624 0.90 JAK2 (0.62) JAK2JAK1GPR119STSTP53
SCHEMBL649847 0.88 KCNK3 (0.55) JAK2JAK1GPR119STS
SCHEMBL584450 0.88 KCNK3 (0.55) JAK2JAK1GPR119STS
SCHEMBL16053284 0.88 KCNK3 (0.55) JAK2JAK1GPR119STS
SCHEMBL6636263 0.88 JAK2 (0.52) JAK2JAK1GPR119STSBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1061076-A1 N-ACYL CYCLIC AMINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-12-20 EP disclosed
US-6140333-A FOR TREATMENT AND/OR PROPHYLAXIS OF DISEASES INCLUDE SUCH RESPIRATORY DISEASES AS CHRONIC OBSTRUCTIVE PULMONARY DISEASES, CHRONIC BRONCHITIS, ASTHMA, CHRONIC RESPIRATORY OBSTRUCTION, PULMONARY FIBROSIS, PULMONARY EMPHYSEMA BANYU PHARMACEUTICAL CO LTD (JP) 2000-10-31 US disclosed